These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 11364470

  • 21. Endemic mycosis complicating human immunodeficiency virus infection.
    Sarosi GA, DAvies SF.
    West J Med; 1996 Apr; 164(4):335-40. PubMed ID: 8732733
    [Abstract] [Full Text] [Related]

  • 22. Drug treatment of the systemic mycoses.
    Newberry WM.
    Semin Drug Treat; 1972 Apr; 2(3):313-29. PubMed ID: 4617926
    [No Abstract] [Full Text] [Related]

  • 23. Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis.
    González GM, Tijerina R, Najvar LK, Bocanegra R, Rinaldi MG, Graybill JR.
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2140-3. PubMed ID: 15155212
    [Abstract] [Full Text] [Related]

  • 24. Lipid formulations of amphotericin B.
    Dix SP, Andriole VT.
    Curr Clin Top Infect Dis; 2000 Jun; 20():1-23. PubMed ID: 10943516
    [Abstract] [Full Text] [Related]

  • 25. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases].
    Karthaus M, Böhme A.
    Wien Med Wochenschr; 2001 Jun; 151(3-4):80-8. PubMed ID: 11789423
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Fungal infection and fever of unknown origin in neutropenic patients.
    Bodey GP.
    Am J Med; 1986 May 30; 80(5C):112-9. PubMed ID: 3717185
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Liposome amphotericin in the treatment of deep mycoses in patients not severely immunosuppressed. An efficient alternative with low toxicity].
    Fernández B de Quirós J, Telenti M, Fernández Castro A, Mateos V, Arnáez Moral E.
    Med Clin (Barc); 1993 Oct 09; 101(11):421-3. PubMed ID: 8231358
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Treatment of systemic fungal infections with liposomal amphotericin B.
    Lopez-Berestein G, Bodey GP, Fainstein V, Keating M, Frankel LS, Zeluff B, Gentry L, Mehta K.
    Arch Intern Med; 1989 Nov 09; 149(11):2533-6. PubMed ID: 2818111
    [Abstract] [Full Text] [Related]

  • 34. [Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
    Glasmacher A, Just-Nübling G, Molitor E.
    Dtsch Med Wochenschr; 1998 Feb 13; 123(7):191-4. PubMed ID: 9505945
    [No Abstract] [Full Text] [Related]

  • 35. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].
    Rieger CT, Dittmer M, Ostermann H.
    Dtsch Med Wochenschr; 2007 Oct 13; 132(40):2062-6. PubMed ID: 17899499
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Diagnosis and treatment of invasive fungal infections focus on liposomal amphotericin B.
    Lacerda JF, Oliveira CM.
    Clin Drug Investig; 2013 Feb 13; 33 Suppl 1():S5-14. PubMed ID: 23381977
    [Abstract] [Full Text] [Related]

  • 38. Treatment of fungal infections in patients infected with the human immunodeficiency virus.
    Sugar AM.
    Pharmacotherapy; 1990 Feb 13; 10(6 ( Pt 3)):154S-158S. PubMed ID: 2075115
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Fungal infections--diagnosis, pathogens and therapy].
    Willinger B.
    Wien Med Wochenschr; 2007 Feb 13; 157(19-20):530-2. PubMed ID: 18030560
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.